ANI Pharmaceuticals, Inc. is a high-risk Pharmaceuticals company based in the United States of America. They specialize in developing, manufacturing, and marketing generic prescription pharmaceuticals, including a wide range of products such as narcotics, hormones, steroids, and complex formulations. With a focus on ESG practices, ANI Pharmaceuticals is known for its liquid, powder, and oral solid dose products. The company's primary revenue comes from the United States and Canada, making it a key player in the pharmaceutical industry.